CTI BioPharma Corp.
Patents, Design & Utilities
Last updated:
List of all CTI BioPharma Corp. patents 6 in total
| Status | Patent |
|---|---|
Application | Utility: OXYGEN LINKED PYRIMIDINE DERIVATIVES Filling date: 25 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: METHODS OF TREATING FLT3-MUTATED HEMATOLOGIC CANCERS Filling date: 25 Sep 2025 Issue date: 13 Jan 2022 |
Grant | Utility: Oxygen linked pyrimidine derivatives Filling date: 25 Sep 2025 Issue date: 5 Oct 2021 |
Application | Utility: METHODS OF TREATING TRANSPLANT REJECTION Filling date: 25 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: OXYGEN LINKED PYRIMIDINE DERIVATIVES Filling date: 25 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Oxygen linked pyrimidine derivatives Filling date: 25 Sep 2025 Issue date: 31 Dec 2019 |
Showing 1 to 6 of 6 patents.